SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-055722
Filing Date
2021-11-09
Accepted
2021-11-09 16:10:23
Documents
14
Period of Report
2021-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rna-8k_20211109.htm   iXBRL 8-K 37752
2 EX-99.1 rna-ex991_6.htm EX-99.1 280006
3 GRAPHIC gokzs31bvtvh000001.jpg GRAPHIC 206622
  Complete submission text file 0001564590-21-055722.txt   714225

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA rna-20211109.xsd EX-101.SCH 5722
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE rna-20211109_lab.xml EX-101.LAB 20078
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rna-20211109_pre.xml EX-101.PRE 11962
7 EXTRACTED XBRL INSTANCE DOCUMENT rna-8k_20211109_htm.xml XML 3688
Mailing Address 10975 N. TORREY PINES RD., #150 LA JOLLA CA 92037
Business Address 10975 N. TORREY PINES RD., #150 LA JOLLA CA 92037 858-401-7900
Avidity Biosciences, Inc. (Filer) CIK: 0001599901 (see all company filings)

IRS No.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39321 | Film No.: 211392216
SIC: 2834 Pharmaceutical Preparations